| Tên sản phẩm | Empagliflozin |
|---|---|
| Số CAS | 864070-44-0 |
| Công thức phân tử | C23H27ClO7 |
| Trọng lượng phân tử | 450.91 |
| Hình thức | Bột tinh thể màu trắng đến trắng ngà |
| Phương pháp phân tích (HPLC) | ≥98% |
| Mất mát khi sấy khô | ≤0,51 TP3T |
| Hàm lượng tro sau khi đốt | ≤0,11 TP3T |
| Kim loại nặng | ≤10 ppm |
| Điểm nóng chảy | 152-156°C |
| Độ quay riêng | -10° to -15° (c=1, methanol) |
Cần trợ giúp? Liên hệ với đội ngũ của chúng tôi

Từ đồng nghĩa
Empagliflozin, Jardiance, BI-10773, 1-Chloro-4-(β-D-glucopyranos-1-yl)-2-[4-((S)-tetrahydrofuran-3-yloxy)-benzyl]-benzene
Empagliflozin has quietly become one of the most prescribed SGLT2 inhibitors in the world, and it’s not hard to see why. Unlike older diabetes drugs that just push insulin harder, empagliflozin works by telling the kidneys to let go of excess glucose — literally flushing it out through urine. That mechanism not only lowers blood sugar but also delivers a nice side effect: many patients see modest weight loss and a reduction in cardiovascular risk. For a diabetic patient, that’s a triple win.
For manufacturers, empagliflozin is a workhorse API. It’s the active ingredient in Jardiance, which has been shown to reduce cardiovascular death in type 2 diabetes patients — a claim not many oral antidiabetics can make. We supply empagliflozin as a high-purity crystalline powder, with every batch tested to meet strict spec limits. Whether you need 1 kg for R&D or a full drum for production, we’ve got you covered, and our lead times are short enough to keep your line moving.
280 Phố Chính, Tây An, Thiểm Tây, Trung Quốc